Kiva VCF Treatment System (Benvenue Medical/Zimmer) enters KAST trial

Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair announced that over 250 patients have been enrolled in the landmark KAST (Kiva System as a Vertebral Augmentation Treatment - A Safety and Effectiveness Trial) clinical trial. KAST is evaluating Benvenue Medical's Kiva VCF Treatment System in the largest randomized study to date versus the current standard of care, balloon kyphoplasty, in vertebral compression fractures (VCF) common to osteoporosis.The Kiva VCF Treatment System received a CE Mark in February 2009. The KAST is the largest randomized study versus balloon kyphoplasty to date, and it is an IDE study being conducted in support of a future 510(k) market clearance application to the FDA. Zimmer have the rights to distribute the product.